General Surgery

Mitchell C. Posner, MD
Thomas D. Jones Professor of Surgery Chief,
Section of General Surgery Physician-in-Chief,
Comprehensive Cancer Center
Learn More & Contact

Yalini Vigneswaran, MD, MS, is an innovative gastrointestinal surgeon who specializes in esophageal and gastric disorders, including motility disorders, esophageal and gastroesophageal junction cancers, reflux disease and paraesophageal hernias. She has clinical expertise in esophageal surgery, including minimally invasive techniques with robotics and various novel procedures.

Enhancing Patient Outcomes with Tailor-Made Care:
Dr. Yalini Vigneswaran Improves the Quality of Life for Patients with Esophageal and Gastric Disorders

Tailor-made care

When Dr. Vigneswaran was an undergraduate studying chemical engineering, she became intrigued by the field of medicine. What appealed to her most was the opportunity to be a part of a collaborative team working toward a common goal—looking after the holistic needs of each individual patient. Which is exactly what Dr. Vigneswaran finds herself doing today. She and her expert team of esophageal surgeons and specialists work together to build tailored and thoughtful care plans for patients.

Personalized medicine is tremendously important, but especially so for esophageal surgery, as each patient is different from the next, with their own goals. “It’s not just the technical aspects of doing the operations, but it is adjusting to the patient and the scenario—always trying to do what will be best for that individual patient,” said Dr. Vigneswaran. “Even specifically in talking about reflux disease and surgery, there’s not just one size fits all; it has to be tailored to the patient and what their objectives are.” Dr. Vigneswaran and her team pride themselves on practicing personalized surgery.

Improving quality of life

Gastroesophageal reflux disease (GERD), also known as “heartburn,” is manifested by many different symptoms. Reflux is caused by a malfunctioning valve between the esophagus and stomach allowing food, acid and bile to come back up into the esophagus, causing an array of symptoms. Common symptoms can include heartburn, an acid taste in the mouth and regurgitation of food. However, reflux disease may also include such “atypical symptoms” as chronic cough or hoarse voice, particularly detrimental to singers.

Reflux disease significantly impacts patients’ quality of life and their day-to-day living. Yet oftentimes, people don’t associate these symptoms with a disease and they tend to postpone care. Dr. Vigneswaran commonly sees patients who have been struggling with symptoms for years with minimal success with medications or diet modifications to lose weight. “Living with poorly treated reflux disease can actually be quite miserable,” she said.

“Although it’s not a life-or-death situation, the daily symptoms patients struggle with affect how they eat, where they eat, going out in social situations, how they sleep, their voice, how they communicate with people and their interactions with people.”

Yalini Vigneswaran, MD, MS
Assistant Professor of Surgery

Thus many of the surgeries that Dr. Vigneswaran perform aim to improve patients’ quality of life. This can be challenging, as there is a lack of access to information about surgical treatment of the disease despite developments in surgical treatment. “A lot of these patients have been dealing with the disease for so long, and no one has been able to help them,” said the surgeon. “It’s very rewarding for me to see these patients after surgery and how significant their life changes from treatment of their disease.” Surgical treatment options for reflux disease have dramatically expanded over the last 10 years, with high success rates. And at the University of Chicago, Dr. Vigneswaran and her esophageal team continue to work on novel procedures and research to further advance treatment options.

Esophageal Foregut Program

The Esophageal Foregut Program is centered on the disease processes of the esophagus, stomach and small intestine. A large portion of this work includes treatment of GERD, which is actually the most prevalent GI disease disorder in the country, affecting approximately 20 to 30 percent of Americans.

The program’s specialists also treat esophageal motility, swallowing disorders and large diaphragm hernias. A segment of patients have problems with their esophagus muscle working improperly, which leads to problems with swallowing. At the program, there is an expert multidisciplinary team of specialists who jointly diagnose and treat problems of the esophagus.

Although the program is still awaiting its official unveiling through the Digestive Diseases service line, Dr. Vigneswaran has seen a lot of exceptional developments as it comes together. “What has really helped grow our program is bringing novel technologies and advanced treatments to the table, such as LINX and EndoFLIP,” said Dr. Vigneswaran. “LINX is a new device used to treat reflux that we have started placing since I’ve started here. EndoFLIP is another novel diagnostic tool that we use inside and outside the operating room, created to complement traditional diagnostic tests such as high-resolution esophageal manometry and barium esophagram. EndoFLIP really allows for customization of surgery for each patient’s individual anatomy.”

Dr. Vigneswaran can be seen holding a LINX device, which is surgically implanted around the lower end of the esophagus to treat gastroesophageal reflux disease (GERD) in patients who continue to have GERD symptoms despite the use of medical therapy (acid pills such as proton pump inhibitor medications) for the treatment of their reflux.

Dr. Vigneswaran is also incredibly thrilled by how the multidisciplinary aspect and collaborative efforts have blossomed exceptionally well. “Bringing all the players to the table and discussing patients in a multidisciplinary way allows us to really come up with unique and very thoughtful treatment plans, especially for complex patients,” she said. Multidisciplinary care is a vital component for Dr. Vigneswaran’s specialty. The program consists of a large cohort of providers, who meet monthly to discuss cases. The group comprises GI surgeons, esophagologists, interventional gastroenterologists, radiologists, thoracic surgeons and ENT surgeons, as well as speech and swallow therapists. Having this diverse group of experts who perform the most novel diagnostics and procedures really provides the patients with the most efficient and optimal care.

“There’s a lot of potential here, it’s just exciting to keep growing it.”

Yalini Vigneswaran, MD, MS
Assistant Professor of Surgery

Patient population

Reflux disease can affect patients of any age; even children can have pathologic reflux. Patients who have obesity can also often struggle with reflux, which induces an overlap with our obesity program and weight loss surgery for these patients.

Along with reflux disease, obesity is associated with other diseases such as diabetes, high blood pressure and high cholesterol. Dr. Vigneswaran treats patients who come in with a BMI greater than 35, and for this kind of patient, she would recommend gastric bypass for their reflux. Personalized care is essential for successful outcomes. In addition to reflux surgery, she and her team are well-versed in bariatric operations. “It’s important that we do our best to help our patients become as healthy as they can,” said Dr. Vigneswaran. “In some patients it’s not just about the reflux disease, it’s obviously about their entire health, and so in treating those patients, we can treat their obesity, diabetes, hypertension, as well as their reflux with the correctly chosen procedure.”

In order for the surgery to be successful, an array of moving parts must be in place. Patients should understand that the road to recovery involves significant changes. While Dr. Vigneswaran and her team meticulously put the tailored tools in place, it is up to the patient to construct their destiny. Health and lifestyle changes are indispensable parts to living a full life after surgery, and studies show that those patients who bring a substantial amount of effort to the table are rewarded with successful long-term outcomes.

Trust fall

Dr. Vigneswaran attributes her growth to senior faculty within the Section of General Surgery. “John C. Alverdy, MD, Executive Vice Chair, has really helped push me in terms of the academic aspects of surgery with research, and not being afraid to try new things,” she said. “He consistently encourages me to be an innovator in the field, in terms of enhancing my clinical practice.”

Dr. Vigneswaran is appreciative of the organic support within the Section of General Surgery and beyond, and how senior faculty have been ardently pushing her forward with her academic goals—especially her surgical partners, Professor of Surgery Vivek N. Prachand, MD, and Associate Professor of Surgery Mustafa Hussain, MD. “I’ve been very fortunate to have a group around me that truly supports me,” she said. “As a new surgeon you really have to have people who are going to have your back if something goes wrong or if you’re trying to do something new.”

For Dr. Vigneswaran, finding people who not only looked like her, but also who went through similar experiences allowed her to enrich her arsenal of resources. “As a young female surgeon, it can be difficult,” she said. “Having more senior people, even in other departments, who have been there and who have gone through it can motivate you to keep getting through. It is very important, because I think it’s really easy to get discouraged very quickly.”

Dr. Vigneswaran is a well-respected surgeon in the field of general surgery, and her brilliant contributions to the department are treasured.

“As a surgeon, the learning never ceases; to that end, total absorption is vital throughout the foundational periods.”

Although impostor syndrome may attempt to contaminate the burgeoning mind, it is crucial to trust the process. “I think to trust that you’ve been trained properly is very important, because then you can take that off the table,” she said. “Once that’s established, you never have to second-guess that you know how to do something; steer clear of impostor syndrome.”

She encourages trainees to build varied connections with everyone, whether it’s the nurses, staff, other referring providers or other administrators in the section. “My advice is to make sure not only that you surround yourself in the right environment, but that you really make an active and intentional effort to develop all of those relationships,” said Dr. Vigneswaran. “It’s extremely beneficial to build diverse relationships; humanity goes a long way.”

Julian T. Owens
Department of Surgery Core Operations Manager
The University of Chicago Medicine

DOWNLOAD PDF

faculty listing

Professor of Surgery
John C. Alverdy, MD, Sara and Harold Lincoln Thompson Professor of Surgery; Executive Vice Chair, Department of Surgery
Peter Angelos, MD, PhD, Linda Kohler Anderson Professor of Surgery and Surgical Ethics; Vice Chairman for Ethics, Professional Development, and Wellness; Chief, Endocrine Surgery; Associate Director, MacLean Center for Clinical Medical Ethics
Nora Jaskowiak, MD, Professor of Surgery; Surgical Director, Breast Center
Edwin L. Kaplan, MD, Professor of Surgery
Jeffrey B. Matthews, MD; Dallas B. Phemister Professor of Surgery; Chair, Department of Surgery; Surgeon-in-Chief, The University of Chicago Medicine
J. Michael Millis, MD, Professor of Surgery; Vice Chair, Global Surgery
Mitchell C. Posner, MD, Thomas D. Jones Professor of Surgery; Professor of Radiation and Cellular Oncology; Chief, Section of General Surgery; Chief, Surgical Oncology; Physician-in-Chief, University of Chicago Medicine Comprehensive Cancer Center
Vivek N. Prachand, MD, Professor of Surgery; Chief Quality Officer, Department of Surgery; Executive Medical Director, Procedural Quality and Safety; Director, Minimally Invasive Surgery; Committee on Molecular Metabolism and Nutrition
Kevin Roggin, MD, Professor of Surgery and Cancer Research; Program Director, General Surgery Residency Program; Associate Director, Complex General Surgical Oncology Fellowship Program
Kiran K. Turaga, MD, MPH, Professor of Surgery; Associate Professor of Obstetrics and Gynecology; Vice Chief, Section of General Surgery and Surgical Oncology (Strategy and Finance); Director, Complex General Surgical Oncology Program; Director, Regional Therapeutics Program

Associate Professor of Surgery
Mustafa Hussain, MD, Associate Professor of Surgery; Director, Center for the Surgical Treatment of Obesity; Associate Program Director, General Surgery
Xavier M. Keutgen, MD, Associate Professor of Surgery; Program Director, Endocrine Surgery Fellowship; Director, Neuroendocrine Tumor Program; Director, Endocrine Surgery Research Program; Co-Director, Von Hippel-Lindau Clinical Care Center

Assistant Professor of Surgery
Oliver Eng, MD, Assistant Professor of Surgery; Associate Program Director, Complex General Surgical Oncology Fellowship
Sarah Shubeck, MD, MS, Assistant Professor of Surgery
Jennifer Tseng, MD, Assistant Professor of Surgery; Associate Program Director, General Surgery Residency; Associate Program Director, Complex General Surgical Oncology Fellowship
Yalini Vigneswaran, MD, MS, Assistant Professor of Surgery

Clinical Associate Professor of Surgery
Patricia L. Turner, MD, Clinical Associate Professor of Surgery

Clinical Associate of Surgery
Ravi Deshmukh, MD, Clinical Associate of Surgery
Krunal Pardiwala, MD, Clinical Associate of Surgery
Paul Signorino, MD, MS, Clinical Associate of Surgery

Research Professor of Surgery
Olga Y. Zaborina, PhD, Research Professor of Surgery

Research Associate Professor of Surgery
Le Shen, MB, PhD, Research Associate Professor of Surgery

Faculty Promotions

Xavier M. Keutgen, MD, Assistant Professor to Associate Professor, effective September 1, 2021

Le Shen, MB, PhD, Research Assistant Professor to Research Associate Professor, effective September 1, 2020

Kiran K. Turaga, MD, MPH, Associate Professor to Professor, effective January 1, 2021

select publications

Vigneswaran Y, Prachand VN, Posner MC, Matthews JB, Hussain M. What Is the Appropriate Use of Laparoscopy over Open Procedures in the Current COVID-19 Climate? Journal of Gastrointestinal Surgery. Jul;24(7):1686-1691, 2020. PMID: 32285338.

Milner R, Donington J, Matthews JB, Posner M, K, Angelos P. Is it ethically appropriate to continue surgical clinical trials during the COVID-19 pandemic? Surgery. Jul;168(1):1-3, 2020. PMID: 32482342.

Prachand VN, Milner R, Angelos P, Posner MC, Fung JJ, Agrawal N, Jeevanandam V, Matthews JB. Medically Necessary, Time-Sensitive Procedures: Scoring System to Ethically and Efficiently Manage Resource Scarcity and Provider Risk During the COVID-19 Pandemic. Journal of the American College of Surgeons. Aug;231(2):281-288, 2020. PMID: 32278725.

Bryan DS, Stack M, Krysztofiak K, Cichoń U, Thomas DG, Surcel A, Schiffhauer ES, Beckett MA, Khodarev NN, Xue L, Poli EC, Pearson AT, Posner MC, Robinson DN, Rock RS, Weichselbaum RR. 4-Hydroxyacetophenone modulates the actomyosin cytoskeleton to reduce metastasis. Proceedings of the National Academy of Sciences of the United States of America. Sep 8;117(36):22423-22429, 2020. PMID: 32848073.

Catenacci DVT, Moya S, Lomnicki S, Chase LM, Peterson BF, Reizine N, Alpert L, Setia N, Xiao SY, Hart J, Siddiqui UD, Hogarth DK, S, K, Roggin K, Posner MC, Chang P, Narula S, Rampurwala M, Ji Y, Karrison T, Liao CY, Polite BN, Kindler HL. Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease. Cancer Discovery. Nov 24. 2020. Online ahead of print. PMID: 33234578.

Liauw SL, Ni L, Wu T, Arif F, Cloutier D, Posner MC, Kozloff M, Kindler HL. A prospective trial of stereotactic body radiation therapy for unresectable pancreatic cancer testing ablative doses. Journal of Gastrointestinal Oncology. Dec;11(6):1399-1407, 2020. PMID: 33457009.

Berger Y, Giurcanu M, Vining CC, Schuitevoerder D, Posner MC, Roggin KK, Polite BN, Liao CY, S, Catenacci DVT, KK. Cytoreductive Surgery for Selected Patients Whose Metastatic Gastric Cancer was Treated with Systemic Chemotherapy. Annals of Surgical Oncology Jan 8, 2021 Online ahead of print. PMID: 33420565.

Golab K, Krzystyniak A, Langa P, Pikuła M, Kunovac S, Borek P, Trzonkowski P, Millis JM, Fung J, Witkowski P. Effect of serum on SmartFlare™ RNA Probes uptake and detection in cultured human cells. Biomed J Sci Tech Res. 2020;28(4):21788-21793. Epub 2020 Jul 2.PMID: 32851205.

Witkowski P, Philipson LH, Kaufman DB, Ratner LE, Abouljoud MS, Bellin MD, Buse JB, Kandeel F, Stock PG, Mulligan DC, Markmann JF, Kozlowski T, Andreoni KA, Alejandro R, Baidal DA, Hardy MA, Wickrema A, Mirmira RG, Fung J, Becker YT, Josephson MA, Bachul PJ, Pyda JS, Charlton M, Millis JM, Gaglia JL, Stratta RJ, Fridell JA, Niederhaus SV, Forbes RC, Jayant K, Robertson RP, Odorico JS, Levy MF, Harland RC, Abrams PL, Olaitan OK, Kandaswamy R, Wellen JR, Japour AJ, Desai CS, Naziruddin B, Balamurugan AN, Barth RN, Ricordi C; “Islets for US” Collaborative. The demise of islet allotransplantation in the United States: A call for an urgent regulatory update. Am J Transplant. 2021 Apr;21(4):1365-1375. Epub 2021 Feb 10.PMID: 33251712.

Generette GS, Bachul PJ, Golab K, Basto L, Pyda JS, Borek P, Tibudan M, Anteby R, Perea L, Charlton M, Perez-Gutierrez A, Jayant K, Lucander A, Matthews JB, Millis JM, Fung J, Witkowski P. En bloc liver and pancreas transplantation after total pancreatectomy with autologous islet transplantation. Eur J Transl Clin Med. 2020;3(2):11-17. Epub 2020 Nov 23.PMID: 33409500.

Nguyen LC, Yang D, Nicolaescu V, Best TJ, Ohtsuki T, Chen SN, Friesen JB, Drayman N, Mohamed A, Dann C, Silva D, Gula H, Jones KA, Millis JM, Dickinson BC, Tay S, Oakes SA, Pauli GF, Meltzer DO, Randall G, Rosner MR. PREPRINT as of 08/24/21 submitted to Science Advances. Cannabidiol Inhibits SARS-CoV-2 Replication and 28 Promotes the Host Innate Immune Response. bioRxiv. 2021 Mar.PMID: 33758843.

Lang P, Keskey R, Hagen E, Millis JM, Prakash P, Wilson K, Zakrison T, Leef J, Ahmed O. Suction thrombectomy and stent grafting of inferior vena cava thrombus following primary repair of traumatic inferior vena cava injury. J Trauma Acute Care Surg. 2021 May 1;90(5):e123-e125. PMID: 33891576.

Bachul PJ, Golab K, Basto L, Zangan S, Pyda JS, Perez-Gutierrez A, Borek P, Wang LJ, Tibudan M, Tran DK, Anteby R, Generette GS, Chrzanowski J, Fendler W, Perea L, Jayant K, Lucander A, Thomas C, Philipson L, Millis JM, Fung J, Witkowski P. Post-Hoc Analysis of a Randomized, Double Blind, Prospective Study at the University of Chicago: Additional Standardizations of Trial Protocol are Needed to Evaluate the Effect of a CXCR1/2 Inhibitor in Islet Allotransplantation. Cell Transplant. 2021 JanDec; PMID: 33908301.

Vining CCC, S, Hogg ME, Schuitevoerder D, Silverman RS, Yao KA, Winchester DJ, Roggin KK, Talamonti MS, Posner MC, KK, Tseng J. Virtual surgical fellowship recruitment during COVID-19 and its implications for resident/fellow recruitment in the future. Ann Surg Oncol, 2020;27(Suppl 3):911-915. PMID 32424589.

Vining CC, Kuchta K, Schuitevoerder D, Paterakos, P, Berger Y, Roggin KK, Talamonti M, Hogg ME. Risk factors for complications in patients undergoing pancreaticoduodenectomy: A NSQIP analysis with propensity score matching. Accepted for publication, J Surg Oncol 2020; 122(2):183-194. PMID 32445612Schwartz PB, Stahl CC, Ethun C, Marka N, Poultsides GA, Roggin KK, Fields RC, Howard JH, Clarke CN, Votanopoulos KI, Cardona K, Abbott DE. Retroperitoneal sarcoma perioperative risk stratification: A United States Sarcoma Collaborative evaluation of the ACS-NSQIP Risk Calculator. J Surg Oncol, 2020;122(2):183-194. PMID 32557654.

Bryan DS, Benjamin AJ, Schneider AB, Milner R, Matthews JB, Roggin KK. Nimble, Together: A training program’s response to the COVID-19 pandemic. Ann Surg, 2020;272(2):142-143. PMD 32355117.

Sell NM, Qadan M, Delman KA, Roggin KK, Spain DA, Phitayakorn R, Lillemoe KD, Mullen JT. Implication of COVID-19 on the General Surgery Match. Ann Surg, 2020;272(2):155-156. PMID 32433297.

Tseng J, Roggin KK, Angelos PA. Should this operation proceed? When residents and faculty disagree during the COVDI-19 pandemic and recovery. Ann Surg, 2020;272(2):157-158. PMID 32433296.

Bryan AF, Milner R, Roggin KK, Angelos P, Matthews JB. Unknown unknowns: Surgical consent during the COVID pandemic. Ann Surg, 2020;272(2):161-162. PMID 32355116.

Wiseman JT, Ethun CG, Cloyd JM, Shelby R, Suarez-Kelly L, Tran T, Poultsides G, Mogal H, Clarke C, Tseng J, Roggin KK, Chouliaras K, Voanopoulos K, KRasnick B, Fields R, Walle KV, Ronnekleiv-Kelly S, Howard JH, Cardona K, Grignol V. Analysis of textbook outcomes among patients undergoing resection of retroperitoneal sarcoma: A multi-institutional analysis of the US Sarcoma Collaborative. J Surg Oncol 2020; 122(6):1189-1198. PMID 32696475.

Strong EA, Park SH, Ethun CG, Chow B, King D, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Gamblin TC, Cardona K, Clarke CN. High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma. Surgery, 2020; 168(4):760-767. PMID 32736869.

Vining CC, Kuchta K, Berger Y, Paterakos P, Schuitevoerder D, Roggin KK, Talamonti M, Hogg ME. Robotic pancreaticoduodenectomy decreases the risk of clinically relevant post-operative pancreatic fistula: A propensity score matched NSQIP analysis. HPB 2020; S1365- 182X(20)31094-7. PMID 32811765.

Lee RM, Ethun CG, Zaidi MY, Tran TB, Poultsides GA, Grignol VP, Howard JH, Bed M, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Oskouei SV, Monson DK, Reimer NB, Maithel SK, Cardona K. A closer look at the natural history and recurrence patterns of high-grade truncal/extremity leiomyosarcomas: A multiinstitutional analysis from the US Sarcoma Collaborative. Surg Oncol 2020; 34:292-297. PMID 32891345.

Stahl CC, Schwartz PB, Ethun CG, Marka N, Krasnick BA, Tran TB, Poultsides GA, Roggin KK, Fields RC, Clarke CN, Votanopoulos KI, Cardona K, Abbott DE. Renal function after retroperitoneal sarcoma resection with nephrectomy: A matched analysis of the United States Sarcoma Collaborative Database. Ann Surg Oncol, 2020; 28(3):1690-1696. PMID 33146839.

Chouliaras K, Patel N, Senehi R, Ethun CG, Poultsides G, Grignol V, Gamblin TC, Roggin KK, Fields RC, D’Agostino R Jr, Levine EA, Cardona K, Votanopoulos K. Impact of resection margin on outcomes in high-grade soft tissue sarcomas of the extremity- A USSC analysis. J Surg Oncol, 2020;123(2):479-488. PMID 33150594.

Catenacci DVT, Moya S, Lomnicki S, Chase LM, Peterson BF, Reizine N, Alpert L, Setia N, Xiao SY, Hart J, Siddiqui UD, Hogarth K, S, K, Roggin K, Posner MC, Chang P, Narula S, Rampurwala M, Ji Y, Karrison T, Liao CY, Polite BN, Kindler HL. Personalized antibodies for gastroesophageal adenocarcinoma (PANGEA): a phase 2 study evaluating an individualized treatment strategy for metastatic disease. Cancer Discov, 2020;11(2):308-325. PMID 33234578.

Vining CC, Hsu PJ, Miller A, Gajewski TF, Pytel P, Krausz TN, Bauer BS, Millis MJ, Roggin KK. Retrocaval melanotic schwannoma: A case report of novel response to anti-PD1 therapy. Melanoma Res, 2021;31(1):92-97. PMID 33323721.

Schuitevoerder D, Sherman S, Izquierdo F, S, KK. Assessment of the surgical workforce pertaining to cytoreductive surgery and heated intraperitoneal chemotherapy in the United States. Annals of Surgical Oncology. Epub 2020 Jul 6.

S, Blakely AM, Lafaro KJ, Fournier KF, Fackche NT, Johnston F, Dineen S, Powers B, Hendrix R, Lambert LA, Ronnekleiv-Kelly S, Vande Walle K, Grotz TE, Leiting JL, Patel SH, Dhar VK, Baumgartner JM, Lowy AM, Clarke CN, Mogal H, Zaidi MY, Staley CA, Kimbrough C, Cloyd JM, Lee B, Raoof M. Institutional Variation in Recovery After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Opportunity for Enhanced Recovery Pathways. Journal of Surgical Oncology. Epub 2020 Jul 5.

Morgan R, Parsad S, KK, S. HIPEC with Cisplatin in a Patient with a Prior Hypersensitivity Reaction to Systemic Oxaliplatin. Basic & Clinical Pharmacology & Toxicology. Epub 2020 Jul 5.

Gamboa AC, Lee RM, Turgeon MK, Zaidi MY, Kimbrough CW, Grotz TE, Leiting J, Fournier K, Lee AJ, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Mogal H, Patel SH, Lee TC, Lambert LA, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, S, Johnston FM, Greer J, Cloyd JM, Maithel SK, Staley CA. Implications of Postoperative Complications on Survival after Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative. Annals of Surgical Oncology. Epub 2020 Jul 21.

Liu JB, Schuitevoerder D, Vining CC, Berger Y, KK, S. Benchmarking Perioperative Outcomes of Cytoreductive Surgery for Cancer: Implications for Quality Measurement. Annals of Surgical Oncology. Epub 2020 Jul 29.

Berger Y, Schuitevoerder D, Vining C, Alpert L, Fenton L, Hindi E, Liao L, Shergill A, Catenacci D, Polite B, K. Novel Application of Iterative Hyperthermic Intraperitoneal Chemotherapy for Unresectable Peritoneal Metastases from High-grade Appendiceal Ex-goblet Adenocarcinoma. Annals of Surgical Oncology. Epub 2020 Sep 5.

Leiting JL, Day CN, Harmsen WS, Cloyd JM, Abdel-Misih S, Fournier K, Lee AJ, Dineen S, Dessureault S, Veerapongh J, Baumgartner JM, Clarke C, Mogal H, Russell MC, Zaidi MY, Patel SH, Morris MC, Hendrix RJ, Lambert LA, Abbott DE, Pokrzywa C, Raoof M, Johnston FM, Greer J, Grotz TE. The impact of HIPEC vs. EPIC for the treatment of mucinous appendiceal carcinoma: a study from the US HIPEC collaborative. International Journal of Hyperthermia. 2020;37(1):1182-1188.

Reizine N, Peterson B, Moya S, Wang Y, Tan C, S, Bilimoria M, Lengyel E, K, Catenacci DV. Complete response in chemorefractory EGFR amplified and PD-L1 positive metastatic gastric cancer patient with dual anti-EGFR and anti-PD-1 monoclonal antibody therapy. JCO Precision Oncology. 2020 Oct 2;4:PO20.00239.

White MG, Schulte J, Xue L, Berger Y, Schuitevoerder D, Vining C, Kindler H, Husain AN, K, S. Heterogeneity in PD-L1 Expression in Malignant Peritoneal Mesothelioma with Systemic or Intraperitoneal Chemotherapy. British Journal of Cancer. Epub 2020 Oct 26.

Wiseman JT, Abdel-Misih S, Beal EW, Zaidi MY, Staley CA, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Raoof M, , Fackche N, Greer J, Pawlik TM, Cloyd JM. A multi-institutional analysis of Textbook Outcomes among patients undergoing cytoreductive surgery for peritoneal surface malignancies. Surgical Oncology. Epub 2021 Nov 20.

Catenacci D, Moya S, Lomnicki S, Chase L, Peterson B, Reizine N, Alpert L, Setia N, Xiao S, Hart J, Siddiqui U, Hogarth K, S, K, Roggin K, Posner M, Chang P, Narula S, Rampurwala M, Ji Y, Karrison T, Liao C, Polite B, Kindler H. Personalized antibodies for gastroesophageal adenocarcinoma (PANGEA): a phase 2 study evaluating an individualized treatment strategy for metastatic disease. Cancer Discovery. Epub 2020 Nov 24:CD-20-1408.

Morgan R, Tun S, S. Fast facts and concepts #412. Hyperthermic intraperitoneal chemotherapy (HIPEC): an overview. Journal of Palliative Medicine. 2021 Apr;24(4):621-622.

Berger Y, Giurcanu M, Vining CC, Schuitevoerder D, Posner MC, Roggin KK, Polite BN, Liao CY, S, Catenacci DVT, KK. Cytoreductive surgery in selected patients with metastatic gastric cancer treated with systemic chemotherapy. Annals of Surgical Oncology. Epub 2021 Jan 8.

Blakely AM, S, Nelson RA, Erhunmwunsee L, Raz DJ, Paz IB, Kim JY. Results of Comprehensive Dysphagia Evaluation and Delayed Oral Intake Following Esophagectomy. Accepted to Annals of Esophagus.

Goldberg EM, Berger Y, Sood D, Kurnit KC, Kim JS, Lee NK, Yamada SD, KK, S. Differences in Sociodemographic Disparities in Patients Undergoing Surgery for Advanced Colorectal and Ovarian Cancer. Annals of Surgical Oncology. Epub 2021 May 6.

S, Pawlik TM, Ejaz A. Response to: Comment on Cancer Surgery During COVID-19: How We Move Forward. Annals of Surgery. Epub 2020 Nov 17. (Invited Response).

White MG, S. Response to Comment on Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy. British Journal of Cancer. Epub 2020 Dec 14. (Invited Response).

Morgan RM, Tun S, S. Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a narrative review. Digestive Medicine Research. 2020 Dec 30;3:54. (Invited Review).

Dhiman A, Fenton E, Whitridge J, Belanski J, Petersen W, Macaraeg S, Rangrass G, Shergill A, K. Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: Enhanced Recovery and HIPEC. Annals of Surgical Oncology. Epub 2021 May 5. (Invited Manuscript).

Goldberg EM, S. ASO Author Reflections: Disparities in Access to Cytoreductive Surgery. Accepted to Annals of Surgical Oncology. Epub 2021 May 19. (Invited Manuscript).

Morgan R, Parsad S, KK, S. HIPEC with cisplatin in a patient with a prior hypersensitivity reaction to systemic oxaliplatin. Basic Clin Pharmacol Toxicol. 2020 Jul 5. doi: 10.1111/bcpt.13464. Epub ahead of print. PMID: 32623784.

Schuitevoerder D, Sherman SK, Izquierdo FJ, S, KK. Assessment of the Surgical Workforce Pertaining to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the United States. Ann Surg Oncol. 2020 Sep;27(9):3097-3102. doi: 10.1245/s10434-020-08781-3. Epub 2020 Jul 6. PMID: 32632884.

Garg PK, Kaul P, Choudhary D, KK, Singh MP, Tiwari AR, Arora V, Agrawal N, Rau B, Yendamuri S. Discordance of COVID-19 guidelines for patients with cancer: A systematic review. J Surg Oncol. 2020 Jul 15:10.1002/jso.26110. doi: 10.1002/jso.26110. Epub ahead of print. PMID: 32668034; PMCID: PMC7405271.

Kamm AM, KK. Appendiceal Mucinous Neoplasm: Nurse Education About a Rare and Complex Disease. Clin J Oncol Nurs. 2020 Aug 1;24(4):409-414. doi: 10.1188/20.CJON.409-414. PMID: 32678367.

Liu JB, Schuitevoerder D, Vining CC, Berger Y, KK, S. Benchmarking Perioperative Outcomes of Cytoreductive Surgery for Cancer: Implications for Quality Measurement. Ann Surg Oncol. 2020 Dec;27(13):5039-5046. doi: 10.1245/s10434-020-08815-w. Epub 2020 Jul 29. PMID: 32729047.

Alter R, KK, Lengyel E. Are We Ready for Hyperthermic Intraperitoneal Chemotherapy in the Upfront Treatment of Ovarian Cancer? JAMA Netw Open. 2020 Aug 3;3(8):e2014184. doi: 10.1001/jamanetworkopen.2020.14184. PMID: 32840618.

Berger Y, Schuitevoerder D, Vining CC, Alpert L, Fenton E, Hindi E, Liao CY, Shergill A, Catenacci DVT, Polite BN, S, KK. Novel Application of Iterative Hyperthermic Intraperitoneal Chemotherapy for Unresectable Peritoneal Metastases from High-Grade Appendiceal Ex-Goblet Adenocarcinoma. Ann Surg Oncol. 2020 Sep 5. doi: 10.1245/s10434-020-09064-7. Epub ahead of print. PMID: 32892267.

Chapel DB, Schulte JJ, Absenger G, Attanoos R, Brcic L, Butnor KJ, Chirieac L, Churg A, Galateau-Sallé F, Hiroshima K, Hung YP, Kindler H, Krausz T, Marchevsky A, Mino-Kenudson M, Mueller J, Nabeshima K, KK, Walts AE, Husain AN. Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases. Mod Pathol. 2020 Oct 15. doi: 10.1038/s41379-020-00688-4. Epub ahead of print. PMID: 33060816.

White MG, Schulte JJ, Xue L, Berger Y, Schuitevoerder D, Vining CC, Kindler HL, Husain A, KK, S. Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy. Br J Cancer. 2020 Oct 26. doi: 10.1038/s41416-020-01130-x. Epub ahead of print. PMID: 33100328.

Vining CC, Schuitevoerder D, KK. Ampullary adenocarcinoma: the current state of adjuvant therapies. Hepatobiliary Surg Nutr. 2020 Oct;9(5):647-649. doi: 10.21037/hbsn.2019.11.37. PMID: 33163515; PMCID: PMC7603931.

Hill MV, Ross EA, Crawford D, Lai L, KK, Grubbs EG, Mullen J, Dineen S, D’Angelica M, Reddy S, Farma JM. Program and candidate experience with virtual interviews for the 2020 Complex General Surgical Oncology interview season during the COVID pandemic. Am J Surg. 2020 Nov 9:S0002-9610(20)30730-3. doi: 10.1016/j.amjsurg.2020.11.007. Epub ahead of print. PMID: 33189309.

Vigneswaran Y (Editor), Alverdy J (Editor). Difficult Decisions in Bariatric Surgery. Springer Nature. 2020.

Vigneswaran Y, Prachand VN, Posner< MC, Matthews JB, Hussain M. What Is theAppropriate Use of Laparoscopy over Open Procedures in the Current COVID-19 Climate? J Gastrointest Surg 2020 Jul;24(7):1686-1691.

Zhang L, Symallah T, Matthews JB, Roggin KK, Hussain M. Creation of a COVID-19 based educational curriculum: A blueprint for redesigning surgical education during times of national crisis. Annals of Surgery OPEN vol 2 Feb 2021.

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Neuroendocrine Tumors. Chicago Consensus Working Group. Ann Surg Oncol. 2020 Jun;27(6):1788-1792. PMID: 32285274.

The Chicago Consensus on Peritoneal Surface Malignancies: Standards. Chicago Consensus Working Group. Ann Surg Oncol. 2020 Jun;27(6):1743-1752. PMID: 32285276.

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms. Ann Surg Oncol. 2020 Jun;27(6):1753-1760. PMID: 32285275.

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Management of Peritoneal Mesothelioma. Chicago Consensus Working Group. Ann Surg Oncol. 2020 Jun;27(6):1774-1779. PMID: 32285273.

The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations. Chicago Consensus Working Group. Ann Surg Oncol. 2020 Jun;27(6):1798-1804. PMID: 32285272.

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms. Chicago Consensus Working Group. Ann Surg Oncol. 2020 Jun;27(6):1780-1787. PMID: 32285271.

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases. Chicago Consensus Working Group. Ann Surg Oncol. 2020 Jun;27(6):1761-1767. PMID: 32285270.

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases. Chicago Consensus Working Group. Ann Surg Oncol. 2020 Jun;27(6):1768-1773. PMID: 32285269.

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors. Chicago Consensus Working Group. Ann Surg Oncol. 2020 Jun;27(6):1793-1797. PMID: 32285268.

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Neuroendocrine Tumors. Chicago Consensus Working Group. Cancer. 2020 Jun 1;126(11):2561-2565. PMID: 32282069.

The Chicago Consensus on Peritoneal Surface Malignancies: Standards. Chicago Consensus Working Group. Cancer. 2020 Jun 1;126(11):2516-2524. PMID: 32282066.

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms. Cancer. 2020 Jun 1;126(11):2525-2533. PMID: 32282073.

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Management of Peritoneal Mesothelioma. Chicago Consensus Working Group. Cancer. 2020 Jun 1;126(11):2547-2552. PMID: 32282077.

The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations. Chicago Consensus Working Group. Cancer. 2020 Jun 1;126(11):2571-2576. PMID: 32282059.

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms. Chicago Consensus Working Group. Cancer. 2020 Jun 1;126(11):2553-2560. PMID: 32282068.

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases. Chicago Consensus Working Group. Cancer. 2020 Jun 1;126(11):2534-2540. PMID: 32282070.

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases. Chicago Consensus Working Group. Cancer. 2020 Jun 1;126(11):2541-2546. PMID: 32282074.

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors. Chicago Consensus Working Group. Cancer. 2020 Jun 1;126(11):2566-2570. PMID: 32282072.

Tierney J, Vogl A, Chivukula SV, Min IM, Scognamiglio T, Gattuso P, Pappas SG, Fahey TJ, Keutgen XM; Indoleamine-2, 3-dioxygenase 1 (IDO-1) as a potential novel target for Adrenocortical Carcinoma; J Surg Res. 2020 Dec;256:90-95. PMID: 32683062.

Vaghaiwalla T, Ruhle B, Memeh K, Angelos P, Kaplan E, Liao CY, Polite B, Keutgen XM; Response rates in metastatic neuroendocrine tumors receiving peptide receptor radionuclide therapy and implications for future treatment strategies. Surgery. 2021 Jan;169(1):162-167. PMID: 32446596.

Memeh K, Ruhle B, Vaghaiwalla T, Kaplan E, Keutgen X, Angelos P; Thyroidectomy for euthyroid patients with Hashimoto thyroiditis and persisting symptoms: A cost-effectiveness analysis. Surgery. 2021 Jan;169(1):7-13. PMID: 32460999.

Dolezal JM, Trzcinska A, Liao CY, Kochanny S, Blair E, Agrawal N, Keutgen XM, Angelos P, Cipriani NA, Pearson AT; Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear features. Mod Pathol. 2021 May;34(5):862-874. PMID: 33299111.

Chatani PD, Aversa JG, McDonald JD, Khan TM, Keutgen XM, Nilubol N; Preoperative serum chromogranin-a is predictive of survival in locoregional jejuno-ileal small bowel neuroendocrine tumors. Surgery. 2021 Apr 1:S0039-6060(21)00086-6. PMID: 33814188.

Memeh K, Ruhle B, Alsafran S, Vaghaiwalla T, Kaplan E, Angelos P, KeutgenXM; Total Thyroidectomy vs Thyroid Lobectomy for Localized Papillary Thyroid Cancer in Children: A Propensity-Matched Survival Analysis.; J Am Coll Surg. 2021 Apr 3:S1072-7515(21)00241-6. PMID: 33887483.

Keutgen XM, Ornell KJ, Vogle A, Lakiza O, Williams J, Miller P, Mistretta KS, Setia N, Weichselbaum RR, Coburn JM; Sunitinib-loaded chondroitin sulfate hydrogels as a novel drug delivery mechanism for the treatment of pancreatic neuroendocrine tumors; Ann Surg Oncol, 2021 Jun 5. Online ahead of print. PMID: 34091777.

Teven CM, Angelos P. Comfort care after self-immolation: Is the physician complicit? Am J Bioeth. 2020 Aug;20(8):123-125. doi: 10.1080/15265161.2020.1782514. PMID: 32757926.

Ronen O, Robbins KT, Olsen KD, Shaha AR, Randolph GW, Nixon IJ, Zafereo ME, Hartl DM, Kowalski LP, Rodrigo JP, Coca-Pelaz A, Mäkitie AA, Vander Poorten V, Sanabria A, Angelos P, Rinaldo A, Ferlito A. Case for staged thyroidectomy. Head Neck. 2020 Oct;42(10):3061-3071. doi: 10.1002/hed.26393. Epub 2020 Aug 6. PMID: 32761849.

Singer MC, Marchal F, Angelos P, Bernet V, Boucai L, Buchholzer S, Burkey B, Eisele D, Erkul E, Faure F, Freitag SK, Gillespie MB, Harrell RM, Hartl D, Haymart M, Leffert J, Mandel S, Miller BS, Morris J, Pearce EN, Rahmati R, Ryan WR, Schaitkin B, Schlumberger M, Stack BC, Van Nostrand D, Wong KK, Randolph G. Salivary and lacrimal dysfunction after radioactive iodine for differentiated thyroid cancer: American Head and Neck Society Endocrine Surgery Section and Salivary Gland Section joint multidisciplinary clinical consensus statement of otolaryngology, ophthalmology, nuclear medicine and endocrinology. Head Neck. 2020 Nov;42(11):3446-3459. doi: 10.1002/hed.26417. Epub 2020 Aug 19. PMID: 32812307.

Perrier ND, Angelos P. Distant-access robotic thyroidectomy—Is it worth the cost? JAMA Surg. 2020 Nov 1;155(11):1010-1012. doi: 10.1001/jamasurg.2020.1491. PMID: 32838421.

Cobianchi L, Dal Mas F, Peloso A, Pugliese L, Massaro M, Bagnoli C, Angelos P. Planning the full recovery phase: an antifragile perspective on surgery after COVID-19. Ann Surg. 2020 Dec;272(6):e296-e299. doi: 10.1097/SLA.0000000000004489. PMID: 32941268.

Dhillon VK, Randolph GW, Stack BC Jr, Lindeman B, Bloom G, Sinclair CF, Woodson G, Brooks JA, Childs LF, Esfandiari NH, Evangelista L, Guardiani E, Quintanilla-Dieck L, Naunheim MR, Shindo M, Singer M, Tolley N, Angelos P, Kupfer R, Banuchi V, Liddy W, Tufano RP. Immediate and partial neural dysfunction after thyroid and parathyroid surgery: Need for recognition, laryngeal exam, and early treatment. Head Neck. 2020 Dec;42(12):3779-3794. doi: 10.1002/hed.26472. Epub 2020 Sep 21. PMID: 32954575.

Jansen MO, Angelos P, Schrantz SJ, Donington JS, Madariaga MLL, Zakrison TL. Fair and equitable subject selection in concurrent COVID-19 clinical trials. J Med Ethics. 2021 Jan;47(1):7-11. doi: 10.1136/medethics-2020-106590. Epub 2020 Oct 12. PMID: 33046590.

Arca MJ, Adams RB, Angelos P, Fanelli RD, Mammen JMV, Nelson MT, Neumeister MW, Robinson AJ, Buyske J. American Board of Surgery statement on assessment and robotic surgery. Am J Surg. 2020 Oct 17:S0002-9610(20)30608-5. doi: 10.1016/j.amjsurg.2020.09.039. PMID: 33097190.

Asimakopoulos P, Shaha AR, Nixon IJ, Shah JP, Randolph GW, Angelos P, Zafereo ME, Kowalski LP, Hartl DM, Olsen KD, Rodrigo JP, Vander Poorten V, Mäkitie AA, Sanabria A, Suárez C, Quer M, Civantos FJ, Robbins KT, Guntinas-Lichius O, Hamoir M, Rinaldo A, Ferlito A. Management of the neck in well-differentiated cancer. Curr Oncol Rep. 2020 Nov 14;23(1):1. doi: 10.1007/s11912-020-00997-6. PMID: 33190176.

Angelos P, Devon K, Ferreres AR, McLeod R, Ellison EC. A crucial moment for reflection on the importance of ethical leadership in academic medicine. Ann Surg. 2021 Feb 1;273(2):e46-e49. doi: 10.1097/SLA.0000000000004600. PMID: 33196491.

Cobianchi L, Dal Mas F, Angelos P. One size does not fit all—Translating knowledge to bridge the gaps to diversity and inclusion of surgical teams. Ann Surg. 2021 Feb 1;273(2):e34-e36. doi: 10.1097/SLA.0000000000004604. PMID: 33201134.

Dolezal JM, Trzcinska A, Liao CY, Kochanny S, Blair E, Agrawal N, Keutgen XM, Angelos P, Cipriani NA, Pearson AT. Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear features. Mod Pathol. 2020 Dec 10. doi: 10.1038/s41379-020-00724-3. PMID: 33299111.

Stack BC Jr, Twining C, Rastatter J, Angelos P, Baloch Z, Diercks G, Faquin W, Kazahaya K, Rivkees S, Sheyn T, Shin JJ, Smith J, Thompson G, Viswanathan P, Wassner A, Brooks J, Randolph G. Consensus statement by the American Association of Clinical Endocrinologists and the American Head and Neck Society Endocrine Surgery Section on pediatric benign and malignant thyroid surgery. Head Neck. 2021 Jan 1. doi: 10.1002/hed.26586. PMID: 33386657.

Stack BC Jr, Twining C, Rastatter J, Angelos P, Baloch Z, Diercks G, Faquin W, Kazahaya K, Rivkees S, Sheyn T, Shin JJ, Smith J, Thompson G, Viswanathan P, Wassner A, Brooks J, Randolph G. Consensus statement by the American Association of Clinical Endocrinologists and the American Head and Neck Society Endocrine Surgery Section on pediatric benign and malignant thyroid surgery. Endocr Pract. 2021 Mar;27(3):174-184. doi: 10.1016/j.eprac.2020.12.001. Epub 2020 Dec 10. PMID: 33779552.

Angelos P. Double-edged sword of surgical innovation: Ethical issues of early and late adoption of novel techniques. Br J Surg. 2021 Mar 12;108(2):107-108. doi: 10.1093/bjs/znaa162. PMID: 33711150.

Hartl DM, Zafereo ME, Kowalski LP, Randolph GW, Olsen KD, Fernandez-Alvarez V, Nixon IJ, Shaha AR, Angelos P, Shah JP, Ferlito A. Occlusion of the internal jugular vein in differentiated thyroid carcinoma: Causes and diagnosis. Eur J Surg Oncol. 2021 Jul;47(7):1552-1557. doi: 10.1016/j.ejso.2021.02.021. Epub 2021 Feb 22. PMID: 33642089.

Memeh K, Ruhle B, Alsafran S, Vaghaiwalla T, Kaplan E, Angelos P, Keutgen XM. Total thyroidectomy vs thyroid lobectomy for localized papillary thyroid cancer in children: A propensity-matched survival analysis. J Am Coll Surg. 2021 Jul;233(1):39-49. doi: 10.1016/j.jamcollsurg.2021.03.025. Epub 2021 Apr 19. PMID: 33887483.

Ferrell JK, Shindo ML, Stack BC Jr, Angelos P, Bloom G, Chen AY, Davies L, Irish JC, Kroeker T, McCammon SD, Meltzer C, Orloff LA, Panwar A, Shin JJ, Sinclair CF, Singer MC, Wang TV, Randolph GW. Perioperative pain management and opioid-reduction in head and neck endocrine surgery: An American Head and Neck Society Endocrine Surgery Section consensus statement. Head Neck. 2021 Aug;43(8):2281-2294. doi: 10.1002/hed.26774. Epub 2021 Jun 3. PMID: 34080732.

Mojtahed SA, Boyer NR, Rao SA, Gajewski TF, Tseng J, KK. Cost-Effectiveness Analysis of Adjuvant Therapy for BRAF-Mutant Resected Stage III Melanoma in Medicare Patients. Ann Surg Oncol. 2021 Jun 15. doi: 10.1245/s10434-021-10288-4. Epub ahead of print. PMID: 34129153.

Vining CC, S, Hogg ME, Schuitevoerder D, Silverman RS, Yao KA, Winchester DJ, Roggin KK, Talamonti MS, Posner MC, KK, Tseng J. Virtual Surgical Fellowship Recruitment During COVID-19 and Its Implications for Resident/Fellow Recruitment in the Future. Ann Surg Oncol. 2020 Dec;27(Suppl 3):911-915. doi: 10.1245/s10434-020-08623-2. Epub 2020 May 18. PMID: 32424589; PMCID: PMC7233675.

Rosenberger LH, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, Miller ME, Gallagher KK, Wong J, Neuman HB, Tseng J, Hassinger TE, King TA, Jakub JW. Contemporary Multi-Institutional Cohort of 550 Cases of Phyllodes Tumors (2007-2017) Demonstrates a Need for More Individualized Margin Guidelines. J Clin Oncol. 2021 Jan 20;39(3):178-189. doi: 10.1200/JCO.20.02647. Epub 2020 Dec 10. PMID: 33301374.

Rosenberger LH, Quintana LM, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, Miller ME, Gallagher KK, Wong J, Neuman HB, Tseng J, Hassinger TE, King TA, Jakub JW, Bentley RC, Schnitt SJ. Limited Reporting of Histopathologic Details in a Multi-Institutional Academic Cohort of Phyllodes Tumors: Time for Standardization. Ann Surg Oncol. 2021 May 14. doi: 10.1245/s10434-021-10118-7. Epub ahead of print. PMID: 33990927.

Li S, Tseng J. Phyllodes patients’ perceptions of care: Do they trust their doctors? Breast J. 2021 Mar 28. doi: 10.1111/tbj.14229. Epub ahead of print. PMID: 33779019.

Wiseman JT, Ethun CG, Cloyd JM, Shelby R, Suarez-Kelly L, Tran T, Poultsides G, Mogal H, Clarke C, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick B, Fields R, Walle KV, Ronnekleiv-Kelly S, Howard JH, Cardona K, Grignol V. Analysis of textbook outcomes among patients undergoing resection of retroperitoneal sarcoma: A multi-institutional analysis of the US Sarcoma Collaborative. J Surg Oncol. 2020 Nov;122(6):1189-1198. doi: 10.1002/jso.26136. Epub 2020 Jul 21. PMID: 32696475.

Volodarskaya M, Tucker AB, Tseng J. Medical Student Research in Surgery: From Abstract Presentation to Publication. J Surg Educ. 2020 Nov-Dec;77(6):1450-1453. doi: 10.1016/j.jsurg.2020.05.011. Epub 2020 Jun 12. PMID: 32540121.

Lee RM, Ethun CG, Zaidi MY, Tran TB, Grignol V, Howard JH, Bedi M, Gamblin T, Tseng J, Roggin KK, Chouliaras K, Votanopoulos KI, Krasnick BA, Fields RC, Oskouei S, Monson D, Reimer NB, Maithel S, Cardona K. A Closer Look at the Natural History and Recurrence Patterns of High-Grade Truncal/Extremity Leiomyosarcomas: An Analysis from the U.S. Sarcoma Collaborative. Surg Oncol. 2020 Sep;34:292-297. doi: 10.1016/j.suronc.2020.06.003. Epub 2020 Jun 30. PMID: 32891345.

Zhao F, Copley B, Niu Q, Johnson JA, Sutton T, Khramtsova G, Sveen E, Yoshimatsu TF, Zheng Y, Ibraheem A, Jaskowiak N, Nanda R, Fleming G, Olopade OI, Huo D, 2021, Racial Disparities in survival outcomes among breast cancer patients by molecular subtypes. Breast Cancer ResTreat. 185(3):841-849.

Shang L, Hattori M, Fleming G, Jaskowiak N, Hedeker D, Olopade OI, Huo D, 2021, Impact of post-diagnosis weight change on survival outcomes in Black and White breast cancer patients. Breast Cancer Res. 23(1).

Gonzalez-Ericsson PI, Wulfkhule JD, Gallagher RI, Sun X, Axelrod ML, Sheng Q, Luo N, Gomez H, Sanchez V, Sanders M, Pusztai L, Petricoin E, Blenman KRM, Balko JM, I-SPY2 Trial Team. 2021, Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti-PD-1/L1 Therapy in Patients with HER2-Negative Primary Breast Cancer. Clin Cancer Res, [online ahead of print].

Kulkarni SA, Kulkarni K, Schacht D, Bhole S, Reiser I, Abe H, Bao J, Bethke K, Hansen N, Jaskowiak N, Khan SA, Tseng J, Chen B, Pincus J, Mueller J, Schulte L, LaBomascus B, Zhang Z, Xia D, Pan X, Wietholt C, Modgil D, Lester D, Lan L, Bohara B, Han X, 2021, ASO Visual Abstract: High-Resolution Full 3D Specimen Imaging for Lumpectomy Margin Assessment in Breast Cancer. Ann Surg Oncol. [online ahead of print].

residents & fellows

View the General Surgery Residents and Fellows here.